609 results on '"Christians U"'
Search Results
52. Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study
53. An automated, highly sensitive LC-MS/MS assay for the quantification of the opiate antagonist naltrexone and its major metabolite 6β-naltrexol in dog and human plasma
54. DIRECT CYTOKINE MEASUREMENT IN URINE AND PLASMA IN A RAT MODEL OF CHRONIC KIDNEY REJECTION
55. Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycin
56. A Single-Dose Pharmacokinetic Study of Myfortic (Mycophenolate Sodium) in Liver Transplant Recipients: Preliminary Findings
57. 52 A SINGLE-DOSE PHARMACOKINETIC STUDY OF MYFORTIC (MYCOPHENOLATE SODIUM) IN LIVER TRANSPLANT RECIPIENTS: PRELIMINARY FINDINGS.: TABLE 1
58. Biologic activity of cyclosporine metabolites
59. Automated Analysis of Antipsychotic Drugs Using Liquid Chromatography with Column Switching
60. Immunoassay Cross-Reactivity Testing of the Major Everolimus Metabolites in the Blood of Kidney Transplant Patients
61. 79 IMMUNOASSAY CROSS-REACTIVITY TESTING OF THE MAJOR EVEROLIMUS METABOLITES IN THE BLOOD OF KIDNEY TRANSPLANT PATIENTS
62. 342 IMMUNOASSAY CROSS-REACTIVITY TESTING OF THE MAJOR EVEROLIMUS METABOLITES IN THE BLOOD OF KIDNEY TRANSPLANT PATIENTS
63. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury
64. Sirolimus (Rapamycin) monotherapy prevents graft vascular disease in non-human primates
65. Red wine decreases cyclosporine bioavailability
66. Co-administration of tacrolimus and mycophenolate mofetil does not increase mycophenolic acid (MPA) exposure, but co-administration of cyclosporine inhibits the enterohepatic recirculation of MPA, thereby decreasing its exposure
67. Membrane transport of mycophenolate mofetil and its active metabolite, mycophenolic acid in MDCK and MDR1-MDCK cell monolayers
68. In vivo effect of sirolimus on T cells, B cells and monocytes in non-human primates.
69. PREVENTION OF ACUTE ALLOGRAFT REJECTION IN NONHUMAN PRIMATE LUNG TRANSPLANT RECIPIENTS
70. COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE (NEORAL) AND SDZ RAD IN NON-HUMAN PRIMATE LUNG TRANSPLANTATION: SYSTEMATIC PHARMACOKINETIC-BASED TRIALS TO IMPROVE EFFICACY AND TOLERABILITY 1
71. TISSUE DISTRIBUTION OF THE NOVEL MACROLIDE IMMUNOSUPPRESSANT SDZ-RAD: INTERACTION WITH CYCLOSPORINE
72. INFLUENCE OF TACROLIMUS ON MYCOPHENOLATE MOFETIL METABOLISM IN AN EX VIVO ISOLATED SMALL BOWEL PERFUSION MODEL*
73. THE NOVEL IMMUNOSUPPRESSANT SDZ-RAD ANTAGONIZES CYCLOSPORINE-INDUCED REDUCTION OF BRAIN ENERGY
74. A FAST, AUTOMATED, AND SPECIFIC ASSAY TO QUANTIFY CYCLOSPORINE AND MACROLIDE IMMUNOSUPPRESSANTS IN BLOOD USING LC/LC-MSD.
75. Chronic Rejection in Non-human Primates: Sirolimus (Rapamycin), but not Cyclosporin, Prevents Graft Vascular Disease (GVD) in Aortic Allografts after Acute Rejection.
76. Basiliximab (αIL2R Mab) induction therapy combined with subtherapeutic doses of neoral and SDZ RAD successfully prevents allograft rejection in a nonhuman primate lung transplant model
77. Coadministration of neoral and the novel rapamycin analog, sdzrad, to lung allograft recipients:potentiation of immunosuppressive efficacy and reduction of toxicity by staggered vs. simultaneous treatment
78. COADMINISTERED NEORAL AND THE NEW RAPAMYCIN DERIVATIVE, SDZ RAD, FOR NONHUMAN PRIMATE LUNG TRANSPLANTATION: SYSTEMATIC PHARMCOKINETIC-BASED TRIALS TO MAXIMIZE EFFICACY AND TOLERABILITY
79. COADMINISTRATION OF MICROEMULSION CYCLOSPORINE AND THE NOVEL LEFLUNOMIDE MALONONITRILAMIDE ANALOG, HR1279, MORE EFFECTIVELY SUPPRESSES RAT LUNG ALLOGRAFT REJECTION THAN MICROEMULSION CYCLOSPORINE PLUS LEFLUNOMIDE
80. Coadministration of neoral and the novel rapamycin analog, sdzrad,to. lung allograft recipients:potentiation of immunosuppressive efficacy and reduction of toxicity by staggered vs. simultaneous treatment
81. 43 SIMULTANEOUS AND AUTOMATED ANALYSIS OF SIROLIMUS AND CICLOSPORIN IN BLOOD
82. 30 NEUROTOXIC EFFECTS OF IMMUNOSUPPRESSANTS INVESTIGATED BY MULTINUCLEAR MRS IN VITRO
83. Evaluation of the Pro- Trac Tacrolimus Monoclonal Whole-Blood Enzyme-Linked Immunosorbent Assay for Monitoring of Tacrolimus Levels in Patients After Kidney, Heart, and Liver Transplantation
84. Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry
85. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients
86. Simplified High-Performance Liquid Chromatography-Mass Spectrometry Assay for Measurement of Tacrolimus and Its Metabolites and Cross-Validation with Microparticle Enzyme Immunoassay
87. 136 TACROLIMUS (FK506) METABOLITE PATTERNS IN BLOOD FROM LIVER AND KIDNEY TRANSPLANT PATIENTS
88. 190 EVALUATION OF THE NEW PRO-TRACR TACROLIMUS MONOCLONAL WHOLE BLOOD ELISA FOR MONITORING OF TACROLIMUS LEVELS IN PATIENTS AFTER KIDNEY, HEART AND LIVER TRANSPLANT
89. 192 SENSITIVE AND SPECIFIC QUANTIFICATION OF SIROLIMUS (RAPAMYCIN) AND ITS METABOLITES IN BLOOD AND URINE OF KIDNEY GRAFT RECIPIENTS USING HPLC/ELECTRO-SPRAY-MASS SPECTROMETRY (LC/ES/MS)
90. 187 CICLOSPORIN METABOLITE PATTERNS AND IMPAIRED KIDNEY FUNCTION IN LIVER GRAFT RECIPIENTS
91. An organotypical in vitro model of the liver parenchyma for uptake studies of diagnostic MR receptor agents
92. Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).
93. Comparison of Different Assays for the Quantitation of FK 506 Levels in Blood or Plasma
94. Use of organotypical cultures of primary hepatocytes to analyse drug biotransformation in man and animals
95. ChemInform Abstract: Structural Investigations of 13‐O‐Demethyl‐FK 506 and Its Isomers Generated by in vitro Metabolism of FK 506 Using Human‐Liver Microsomes.
96. When to Measure Cyclosporin Metabolites in Liver Graft Recipients?
97. In-Vitro Metabolism of FK506, Cytochrome P450 and Drug Interactions
98. Cyclosporin metabolism in transplant patients
99. Specific and Sensitive Measurement of FK506 and Its Metabolites in Blood and Urine of Liver-Graft Recipients
100. FK 506
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.